Ankyrin-based targeting pathway regulates human sinoatrial node automaticity

Area of Science:

• Cardiovascular Physiology
• Molecular Cell Biology
• Genetics

Background:

• Ankyrin proteins are crucial for targeting ion channels and transporters to cell membranes.
• Defects in these pathways are linked to physiological abnormalities and human diseases.
• Cardiac ankyrin-B dysfunction has been implicated in human sinus node disease.

Purpose of the Study:

• To investigate the role of ankyrin-B in cardiac function, specifically within the sinoatrial node (SAN).
• To determine the molecular mechanisms by which ankyrin-B deficiency leads to sinus node dysfunction.
• To explore ankyrin-based pathways as potential therapeutic targets for SAN diseases.

Main Methods:

• Utilized ankyrin-B deficient mice models.
• Isolated sinoatrial node (SAN) cells were studied.
• Examined membrane expression of key ion channels and transporters (NCX1, NKA, IP3R, Ca(V)1.3).
• Assessed calcium (Ca2+) release dynamics and membrane depolarization.

Main Results:

• Ankyrin-B deficient mice exhibited bradycardia and heart rate variability, mirroring human sinus node disease.
• SAN cells lacking ankyrin-B showed altered membrane expression of NCX1, NKA, IP3R, and Ca(V)1.3.
• Loss of ankyrin-B resulted in irregular Ca2+ release and afterdepolarizations in SAN cells.
• Ankyrin-B is essential for proper targeting and function of multiple ion channels and transporters in SAN cells.

Conclusions:

• Ankyrin-B is a critical regulator of ion channel and transporter function in SAN cells, maintaining SR calcium homeostasis and membrane depolarization.
• Ankyrin-B deficiency provides a novel genetic basis for human sinus node disease (SND).
• Ankyrin-based pathways represent promising therapeutic targets for treating SND, potentially requiring a multi-hit strategy.